sodium selenate has been researched along with levorphanol in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (87.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bidlack, JM; Cohen, DJ; DeNunzio, NJ; Gu, XH; Mello, NK; Negus, SS; Neumeyer, JL; Rusovici, DE; van Vliet, LA | 1 |
Bidlack, JM; Gu, XH; Hilbert, JE; Knapp, BI; Mello, NK; Negus, SS; Neumeyer, JL; Xiong, W; Zhang, A | 1 |
Bidlack, JM; Hilbert, JE; Knapp, BI; Neumeyer, JL; Wentland, MP; Xiong, W; Zhang, A | 1 |
Bidlack, JM; DeVita, EK; Hilbert, JE; Neumeyer, JL; Xiong, W; Zhang, A | 1 |
Bidlack, JM; Knapp, BI; Neumeyer, JL; Peng, X | 2 |
Bidlack, JM; Fulton, BS; Knapp, BI; Neumeyer, JL | 1 |
Bidlack, JM; Cohen, DJ; Knapp, BI; Neumeyer, JL; Sromek, AW; Zhang, B; Zhang, T | 1 |
8 other study(ies) available for sodium selenate and levorphanol
Article | Year |
---|---|
Mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine abuse: synthesis and opioid receptor binding affinity of N-substituted derivatives of morphinan.
Topics: Cocaine-Related Disorders; Drug Combinations; Humans; Morphinans; Narcotic Antagonists; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2001 |
Design and synthesis of novel dimeric morphinan ligands for kappa and micro opioid receptors.
Topics: Animals; CHO Cells; Cricetinae; Dimerization; Drug Design; Humans; Ligands; Morphinans; Radioligand Assay; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship | 2003 |
10-Ketomorphinan and 3-substituted-3-desoxymorphinan analogues as mixed kappa and micro opioid ligands: synthesis and biological evaluation of their binding affinity at opioid receptors.
Topics: Animals; Brain; CHO Cells; Cricetinae; Guinea Pigs; Hydrogen Bonding; In Vitro Techniques; Ligands; Models, Molecular; Molecular Conformation; Morphinans; Radioligand Assay; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship | 2004 |
2-aminothiazole-derived opioids. Bioisosteric replacement of phenols.
Topics: Animals; Benzomorphans; CHO Cells; Cricetinae; Morphinans; Morphine Derivatives; Narcotics; Phenols; Radioligand Assay; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship; Thiazoles | 2004 |
Synthesis and preliminary in vitro investigation of bivalent ligands containing homo- and heterodimeric pharmacophores at mu, delta, and kappa opioid receptors.
Topics: Animals; CHO Cells; Cricetinae; Drug Evaluation, Preclinical; Humans; In Vitro Techniques; Ligands; Molecular Conformation; Morphinans; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Stereoisomerism; Structure-Activity Relationship | 2006 |
High-affinity carbamate analogues of morphinan at opioid receptors.
Topics: Animals; Binding, Competitive; Carbamates; Cell Membrane; CHO Cells; Cricetinae; Cricetulus; Guanosine 5'-O-(3-Thiotriphosphate); Ligands; Morphinans; Narcotic Antagonists; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2007 |
Synthesis and pharmacological evaluation of hydrophobic esters and ethers of butorphanol at opioid receptors.
Topics: Animals; Butorphanol; Chemistry, Pharmaceutical; CHO Cells; Cricetinae; Cricetulus; Drug Design; Hydrophobic and Hydrophilic Interactions; Kinetics; Models, Chemical; Narcotic Antagonists; Phenol; Protein Binding; Receptors, Opioid; Temperature | 2008 |
Synthesis, binding affinity, and functional in vitro activity of 3-benzylaminomorphinan and 3-benzylaminomorphine ligands at opioid receptors.
Topics: Animals; Benzylamines; Binding, Competitive; CHO Cells; Cricetinae; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Kinetics; Morphinans; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship | 2012 |